The effect of 5′ and 3′ non-translated regions on the expression of a transgene from a Newcastle disease virus vector

•Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. T...

Full description

Saved in:
Bibliographic Details
Published inVirus research Vol. 341; p. 199309
Main Authors Chowdhury, Ishita Roy, Viktorova, Ekaterina, Samal, Siba K., Belov, George A.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.
AbstractList Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5' and 3' untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5'UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5' and 3' untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5'UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.
Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.
• Cognate UTRs of NDV modulate the expression of transgene. • M UTRs strongly increase transgene expression in hela cells. • HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.
•Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA translation. Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector performance requires a stable high-level expression of a transgene. The foreign genes are usually incorporated in the genome of NDV as individual transcription units, whose transcription and subsequent translation of the mRNA are regulated by the 5′ and 3′ untranslated regions (UTRs) flanking the open reading frame of the transgene. Here, we investigated if the UTRs derived from the cognate NDV genes would increase the expression of a model protective antigene from an NDV vector. Our results show that in chicken DF1 cells, none of the UTRs tested significantly outperformed generic short sequences flanking the transgene, while in human HeLa cells, UTRs derived from the M gene of NDV statistically significantly increased the expression of the transgene. The UTRs derived from the HN gene significantly downregulated the transgene expression in both cell cultures. Further experiments demonstrated that NDV UTRs differently affect the mRNA abundance and translation efficacy. While both M and HN UTRs decreased the level of the transgene mRNA in infected cells compared to the mRNA flanked by generic UTRs, M, and particularly, HN UTRs strongly increased the mRNA translation efficacy. The major determinants of translation enhancement are localized in the 5′UTR of HN. Thus, our data reveal a direct role of NDV UTRs in translational regulation, and inform future optimization of NDV vectors for vaccine and therapeutic use.
ArticleNumber 199309
Author Samal, Siba K.
Belov, George A.
Viktorova, Ekaterina
Chowdhury, Ishita Roy
Author_xml – sequence: 1
  givenname: Ishita Roy
  surname: Chowdhury
  fullname: Chowdhury, Ishita Roy
– sequence: 2
  givenname: Ekaterina
  surname: Viktorova
  fullname: Viktorova, Ekaterina
– sequence: 3
  givenname: Siba K.
  surname: Samal
  fullname: Samal, Siba K.
– sequence: 4
  givenname: George A.
  orcidid: 0000-0002-0892-1731
  surname: Belov
  fullname: Belov, George A.
  email: gbelov@umd.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38181903$$D View this record in MEDLINE/PubMed
BookMark eNqFUstuEzEUtVARTQu_UHnJZoJf48cKUMWjUgWbsrY89p3U0WQc7EmgO76JT-JL8CRtRVesbF2fx_W95wydjGkEhC4oWVJC5Zv1ch_zrmQoS0aYWFJjODHP0IJqxRolDDtBiwrUDVWEnaKzUtaEEMmVfIFOuaaaGsIX6O7mFjD0PfgJpx63f379xm4MmM-X6tlM2Y1lcBMEnGEV01hwGvE0s35uq32ppZnp8AG5ghFwn9OmFr7AD-_KNAAOsYArgA894301S_klet67ocCr-_Mcffv44ebyc3P99dPV5fvrxgvdTo2WnFPOiBdMBllLgjDiJAETwNFO-6C41AyCYsE7zrves9ZQJokToTctP0dXR92Q3Npuc9y4fGeTi_ZQSHllXZ6iH8AeXLpWCUW1cKHVRvVaUtPJVimnuqr19qi13XUbCB7G-unhiejTlzHe2lXaW0rqxJlgVeH1vUJO33dQJruJxcMwuBHSrlhmqFFCtFpVqDxCfU6lbrp_9KHEziGwa_sQAjuHwB5DUIkX_3b5SHvYegW8OwKgzn0fIdviI4weQsx1N3Uw8X8efwGwE8sN
Cites_doi 10.1186/1297-9716-42-38
10.1016/j.coviro.2023.101348
10.1099/vir.0.068437-0
10.20506/rst.19.2.1231
10.3390/v12111249
10.1016/0092-8674(86)90762-2
10.1038/s41598-020-59124-x
10.1128/JVI.00976-18
10.1016/j.vaccine.2019.10.074
10.1099/jgv.0.001761
10.1016/j.psj.2022.102078
10.1093/nar/20.10.2517
10.3390/vaccines8020222
10.1093/nar/14.16.6551
10.1128/JVI.00188-09
10.3390/v12040451
10.1128/JVI.02049-09
10.1016/j.virol.2016.08.018
ContentType Journal Article
Copyright 2024
Copyright © 2024. Published by Elsevier B.V.
2024 The Authors. Published by Elsevier B.V. 2024
Copyright_xml – notice: 2024
– notice: Copyright © 2024. Published by Elsevier B.V.
– notice: 2024 The Authors. Published by Elsevier B.V. 2024
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1016/j.virusres.2024.199309
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1872-7492
ExternalDocumentID oai_doaj_org_article_20c42b5747184ad5897f8619b6577a7b
10_1016_j_virusres_2024_199309
38181903
S0168170224000029
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
0SF
123
1B1
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5RE
5VS
6I.
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMG
HVGLF
HZ~
IH2
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
WH7
WUQ
ZGI
~G-
AAHBH
AAXKI
ADVLN
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c485t-86331320c426d64854020a60e9dea1b8cd73682ed72dca33bfc2591260a4df953
IEDL.DBID RPM
ISSN 0168-1702
1872-7492
IngestDate Tue Oct 22 15:06:01 EDT 2024
Tue Sep 17 21:30:47 EDT 2024
Sat Oct 26 01:51:58 EDT 2024
Thu Sep 26 15:47:23 EDT 2024
Sat Nov 02 12:30:09 EDT 2024
Sat Mar 02 16:00:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords UTR translation control
Vectored vaccines
Transgene expression
Newcastle disease virus vector
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2024. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-86331320c426d64854020a60e9dea1b8cd73682ed72dca33bfc2591260a4df953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD 20993, USA.
Retired.
ORCID 0000-0002-0892-1731
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818242/
PMID 38181903
PQID 2919744587
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_20c42b5747184ad5897f8619b6577a7b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10818242
proquest_miscellaneous_2919744587
crossref_primary_10_1016_j_virusres_2024_199309
pubmed_primary_38181903
elsevier_sciencedirect_doi_10_1016_j_virusres_2024_199309
PublicationCentury 2000
PublicationDate 2024-03-01
PublicationDateYYYYMMDD 2024-03-01
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Virus research
PublicationTitleAlternate Virus Res
PublicationYear 2024
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Hu, Ni, Cao, Liu (bib0005) 2020; 8
Kim, Samal (bib0009) 2010; 84
Shao, Xie, Liang, Liu, Song, Feng, Zhang, Lin, Fu, Xie (bib0013) 2022; 101
Zhao, Zhang, Zsak, Yu (bib0018) 2015; 96
Kolakofsky (bib0010) 2016; 498
Elbehairy, Samal, Belov (bib0004) 2022; 103
Ikeda, Ligman, Warshamana (bib0006) 1992; 20
Viktorova, Khattar, Kouiavskaia, Laassri, Zagorodnyaya, Dragunsky, Samal, Chumakov, Belov (bib0015) 2018; 92
de Swart, Belov (bib0003) 2023; 62
Kozak (bib0011) 1986; 44
Bello, Yusoff, Ideris, Hair-Bejo, Jibril, Peeters, Omar (bib0002) 2020; 12
Ishida, Taira, Omata, Mizumoto, Hattori, Iwasaki, Kawakita (bib0007) 1986; 14
Alexander (bib0001) 2000; 19
Samuel, Subbiah, Shive, Collins, Samal (bib0012) 2011; 42
Shirvani, Varghese, Paldurai, Samal (bib0014) 2020; 10
Yan, Rout, Kim, Samal (bib0016) 2009; 83
Yu, Li, Dimitrov, Afonso, Spatz, Zsak (bib0017) 2020; 38
Jadhav, Zhao, Ledda, Liu, Ding, Nair, Ferretti (bib0008) 2020; 12
Yu (10.1016/j.virusres.2024.199309_bib0017) 2020; 38
Alexander (10.1016/j.virusres.2024.199309_bib0001) 2000; 19
Hu (10.1016/j.virusres.2024.199309_bib0005) 2020; 8
Elbehairy (10.1016/j.virusres.2024.199309_bib0004) 2022; 103
Samuel (10.1016/j.virusres.2024.199309_bib0012) 2011; 42
Kim (10.1016/j.virusres.2024.199309_bib0009) 2010; 84
Bello (10.1016/j.virusres.2024.199309_bib0002) 2020; 12
Ishida (10.1016/j.virusres.2024.199309_bib0007) 1986; 14
Ikeda (10.1016/j.virusres.2024.199309_bib0006) 1992; 20
de Swart (10.1016/j.virusres.2024.199309_bib0003) 2023; 62
Jadhav (10.1016/j.virusres.2024.199309_bib0008) 2020; 12
Shirvani (10.1016/j.virusres.2024.199309_bib0014) 2020; 10
Viktorova (10.1016/j.virusres.2024.199309_bib0015) 2018; 92
Kozak (10.1016/j.virusres.2024.199309_bib0011) 1986; 44
Shao (10.1016/j.virusres.2024.199309_bib0013) 2022; 101
Yan (10.1016/j.virusres.2024.199309_bib0016) 2009; 83
Zhao (10.1016/j.virusres.2024.199309_bib0018) 2015; 96
Kolakofsky (10.1016/j.virusres.2024.199309_bib0010) 2016; 498
References_xml – volume: 12
  start-page: 451
  year: 2020
  ident: bib0002
  article-title: Exploring the prospects of engineered newcastle disease virus in modern vaccinology
  publication-title: Viruses Basel
  contributor:
    fullname: Omar
– volume: 84
  start-page: 2629
  year: 2010
  end-page: 2634
  ident: bib0009
  article-title: Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein
  publication-title: J. Virol.
  contributor:
    fullname: Samal
– volume: 10
  start-page: 2221
  year: 2020
  ident: bib0014
  article-title: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
  publication-title: Sci. Rep.
  contributor:
    fullname: Samal
– volume: 96
  start-page: 40
  year: 2015
  end-page: 45
  ident: bib0018
  article-title: P and M gene junction is the optimal insertion site in newcastle disease virus vaccine vector for foreign gene expression
  publication-title: J. Gen. Virol.
  contributor:
    fullname: Yu
– volume: 62
  year: 2023
  ident: bib0003
  article-title: Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines
  publication-title: Curr. Opin. Virol.
  contributor:
    fullname: Belov
– volume: 20
  start-page: 2517
  year: 1992
  end-page: 2524
  ident: bib0006
  article-title: T7 promoter contacts essential for promoter activity
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Warshamana
– volume: 14
  start-page: 6551
  year: 1986
  end-page: 6564
  ident: bib0007
  article-title: Sequence of 2,617 nucleotides from the 3′ end of newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Kawakita
– volume: 8
  start-page: 222
  year: 2020
  ident: bib0005
  article-title: Newcastle disease virus as a vaccine vector for 20 years: a focus on maternally derived antibody interference
  publication-title: Vaccines Basel
  contributor:
    fullname: Liu
– volume: 12
  start-page: 1249
  year: 2020
  ident: bib0008
  article-title: Patterns of RNA editing in newcastle disease virus infections
  publication-title: Viruses
  contributor:
    fullname: Ferretti
– volume: 92
  start-page: 00918
  year: 2018
  end-page: 00976
  ident: bib0015
  article-title: Newcastle disease virus-based vectored vaccine against poliomyelitis
  publication-title: J. Virol.
  contributor:
    fullname: Belov
– volume: 42
  start-page: 38
  year: 2011
  ident: bib0012
  article-title: Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9
  publication-title: Vet. Res.
  contributor:
    fullname: Samal
– volume: 38
  start-page: 925
  year: 2020
  end-page: 932
  ident: bib0017
  article-title: Genetic stability of a newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos
  publication-title: Vaccine
  contributor:
    fullname: Zsak
– volume: 44
  start-page: 283
  year: 1986
  end-page: 292
  ident: bib0011
  article-title: Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
  publication-title: Cell
  contributor:
    fullname: Kozak
– volume: 103
  year: 2022
  ident: bib0004
  article-title: Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability
  publication-title: J. Gen. Virol.
  contributor:
    fullname: Belov
– volume: 101
  year: 2022
  ident: bib0013
  article-title: Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract
  publication-title: Poult. Sci.
  contributor:
    fullname: Xie
– volume: 498
  start-page: 94
  year: 2016
  end-page: 98
  ident: bib0010
  article-title: Paramyxovirus RNA synthesis, mRNA editing, and genome hexamer phase: a review
  publication-title: Virology
  contributor:
    fullname: Kolakofsky
– volume: 19
  start-page: 443
  year: 2000
  end-page: 462
  ident: bib0001
  article-title: Newcastle disease and other avian paramyxoviruses
  publication-title: Rev. Sci. Tech.
  contributor:
    fullname: Alexander
– volume: 83
  start-page: 5943
  year: 2009
  end-page: 5946
  ident: bib0016
  article-title: Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus
  publication-title: J. Virol.
  contributor:
    fullname: Samal
– volume: 42
  start-page: 38
  issue: 1
  year: 2011
  ident: 10.1016/j.virusres.2024.199309_bib0012
  article-title: Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9
  publication-title: Vet. Res.
  doi: 10.1186/1297-9716-42-38
  contributor:
    fullname: Samuel
– volume: 62
  year: 2023
  ident: 10.1016/j.virusres.2024.199309_bib0003
  article-title: Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2023.101348
  contributor:
    fullname: de Swart
– volume: 96
  start-page: 40
  issue: Pt 1
  year: 2015
  ident: 10.1016/j.virusres.2024.199309_bib0018
  article-title: P and M gene junction is the optimal insertion site in newcastle disease virus vaccine vector for foreign gene expression
  publication-title: J. Gen. Virol.
  doi: 10.1099/vir.0.068437-0
  contributor:
    fullname: Zhao
– volume: 19
  start-page: 443
  issue: 2
  year: 2000
  ident: 10.1016/j.virusres.2024.199309_bib0001
  article-title: Newcastle disease and other avian paramyxoviruses
  publication-title: Rev. Sci. Tech.
  doi: 10.20506/rst.19.2.1231
  contributor:
    fullname: Alexander
– volume: 12
  start-page: 1249
  issue: 11
  year: 2020
  ident: 10.1016/j.virusres.2024.199309_bib0008
  article-title: Patterns of RNA editing in newcastle disease virus infections
  publication-title: Viruses
  doi: 10.3390/v12111249
  contributor:
    fullname: Jadhav
– volume: 44
  start-page: 283
  issue: 2
  year: 1986
  ident: 10.1016/j.virusres.2024.199309_bib0011
  article-title: Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
  publication-title: Cell
  doi: 10.1016/0092-8674(86)90762-2
  contributor:
    fullname: Kozak
– volume: 10
  start-page: 2221
  issue: 1
  year: 2020
  ident: 10.1016/j.virusres.2024.199309_bib0014
  article-title: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-59124-x
  contributor:
    fullname: Shirvani
– volume: 92
  start-page: 00918
  issue: 17
  year: 2018
  ident: 10.1016/j.virusres.2024.199309_bib0015
  article-title: Newcastle disease virus-based vectored vaccine against poliomyelitis
  publication-title: J. Virol.
  doi: 10.1128/JVI.00976-18
  contributor:
    fullname: Viktorova
– volume: 38
  start-page: 925
  issue: 4
  year: 2020
  ident: 10.1016/j.virusres.2024.199309_bib0017
  article-title: Genetic stability of a newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2019.10.074
  contributor:
    fullname: Yu
– volume: 103
  issue: 6
  year: 2022
  ident: 10.1016/j.virusres.2024.199309_bib0004
  article-title: Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability
  publication-title: J. Gen. Virol.
  doi: 10.1099/jgv.0.001761
  contributor:
    fullname: Elbehairy
– volume: 101
  issue: 12
  year: 2022
  ident: 10.1016/j.virusres.2024.199309_bib0013
  article-title: Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract
  publication-title: Poult. Sci.
  doi: 10.1016/j.psj.2022.102078
  contributor:
    fullname: Shao
– volume: 20
  start-page: 2517
  issue: 10
  year: 1992
  ident: 10.1016/j.virusres.2024.199309_bib0006
  article-title: T7 promoter contacts essential for promoter activity in vivo
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/20.10.2517
  contributor:
    fullname: Ikeda
– volume: 8
  start-page: 222
  issue: 2
  year: 2020
  ident: 10.1016/j.virusres.2024.199309_bib0005
  article-title: Newcastle disease virus as a vaccine vector for 20 years: a focus on maternally derived antibody interference
  publication-title: Vaccines Basel
  doi: 10.3390/vaccines8020222
  contributor:
    fullname: Hu
– volume: 14
  start-page: 6551
  issue: 16
  year: 1986
  ident: 10.1016/j.virusres.2024.199309_bib0007
  article-title: Sequence of 2,617 nucleotides from the 3′ end of newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/14.16.6551
  contributor:
    fullname: Ishida
– volume: 83
  start-page: 5943
  issue: 11
  year: 2009
  ident: 10.1016/j.virusres.2024.199309_bib0016
  article-title: Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus
  publication-title: J. Virol.
  doi: 10.1128/JVI.00188-09
  contributor:
    fullname: Yan
– volume: 12
  start-page: 451
  issue: 4
  year: 2020
  ident: 10.1016/j.virusres.2024.199309_bib0002
  article-title: Exploring the prospects of engineered newcastle disease virus in modern vaccinology
  publication-title: Viruses Basel
  doi: 10.3390/v12040451
  contributor:
    fullname: Bello
– volume: 84
  start-page: 2629
  issue: 5
  year: 2010
  ident: 10.1016/j.virusres.2024.199309_bib0009
  article-title: Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein
  publication-title: J. Virol.
  doi: 10.1128/JVI.02049-09
  contributor:
    fullname: Kim
– volume: 498
  start-page: 94
  year: 2016
  ident: 10.1016/j.virusres.2024.199309_bib0010
  article-title: Paramyxovirus RNA synthesis, mRNA editing, and genome hexamer phase: a review
  publication-title: Virology
  doi: 10.1016/j.virol.2016.08.018
  contributor:
    fullname: Kolakofsky
SSID ssj0006376
Score 2.4500072
Snippet •Cognate UTRs of NDV modulate the expression of transgene.•M UTRs strongly increase transgene expression in hela cells.•HN 5′UTR promotes efficient mRNA...
Newcastle disease virus (NDV) is an avian virus and a promising vector for the development of vaccines for veterinary and human use. The optimal vaccine vector...
• Cognate UTRs of NDV modulate the expression of transgene. • M UTRs strongly increase transgene expression in hela cells. • HN 5′UTR promotes efficient mRNA...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 199309
SubjectTerms Newcastle disease virus vector
Transgene expression
UTR translation control
Vectored vaccines
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsQwFA0iCG7Et_VFBLdV2zy7VFFEcFYOuAtJ0-KIdEQ6oju_yU_yS7w3aWVGF27clTQtSe5Nc05zcy4hhwwgRQa3gJvUIuW81ingOJdmWpeofetYSDZxM5BXQ359J-6mUn1hTFiUB44DB-S85LkTyJ00t17oQtUaUL-TQimrXPj6nhQ9meq-wRLmzdR54Iejl9HzBNYcFOjOOR7RYxiCOLUUBcX-mRXpN-L8GTg5tRJdLpOlDkLS09j0FTJXNatkISaVfFsjmIqOxjANOq6p-Hz_oLbxlOEFkP20xeXpETCmp5iWAdyOjhva4lOvXVhsg09aGmqCh1UUT6FAwQDTjeDGMO02dmjoMX0J__7XyfDy4vb8Ku0SLKQl16JNtWSo3IgjLL2EIiSTVp5Uha9s5nTpFZM6r7zKfWkZc3UJbCkDCmS5rwvBNsg8tLvaIhSIjS8lau17xYvcWpjrytvSwVjVorYJOe7H2jxFHQ3TB5g9mN46Bq1jonUScoYm-a6NOtihALzDdN5h_vKOhBS9QU0HKSJUgFeN_mzAQe8BBuYcbqTYphpPoFKRAQ3jQquEbEaP-G4mIiAAWSwhesZXZvoxe6cZ3Qdd7wzlBQEybf9Hz3fIIvYlhsvtkvn2eVLtAX5q3X6YKl9ZexrU
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB6VrZC4oPIfKMhIXMM2azt2jm3VagGxF6jUm2XHCaSqkmqVreDGM_FIPAkzjrPawIEDt8Sxo4lnMj-a8TcAbzi6FBk-wtiklqkQtU7Rj3NppnVJ2LeOh2YTH1f58kK8v5SXe3A6noWhssqo-wedHrR1HJnH3ZzfNM38EzorhC4XqiApuXQH9kOSaAb7x-8-LFdbhZzz0GOO5qe0YOeg8NXb22a9QWNEyN0LQWf3ONUm7tioAOU_MVV_u6J_VlTumKjzA7gffUt2PJD_APaq9iHcHbpNfn8E1KOODfUbrKuZ_PXjJ7OtZ5wu2q5Ne7Jb1-h8ekb9GlAeWdeynlZ9i_WyLa20LMxE0asYHU_BgRX1IaGMMYsZHxa-mN2GpMBjuDg_-3y6TGPnhbQUWvapzjlBOh6VaL99jkMUZdr8qCp8ZTOnS694rheVVwtfWs5dXWIYlWFsZIWvC8mfwAzprp4Bw4jHlzmB8HslioW1qASUt6XDvaplbROYj3ttbgaADTNWnl2ZkTuGuGMG7iRwQizZziaA7DDQrb-YKCEm0O4khdxaWC91oWqNwaLLpVJWuQSKkaFmIm_4quafBLweJcDgz0gZFttW3QYnFRnGZ0JqlcDTQSK2ZJJrhN4XT0BPZGXyHdMnbfM1AH5nhDuIvtTz_yD6Bdyju6F87hBm_XpTvUR_qnev4v_yGzL_IT0
  priority: 102
  providerName: Elsevier
Title The effect of 5′ and 3′ non-translated regions on the expression of a transgene from a Newcastle disease virus vector
URI https://dx.doi.org/10.1016/j.virusres.2024.199309
https://www.ncbi.nlm.nih.gov/pubmed/38181903
https://www.proquest.com/docview/2919744587
https://pubmed.ncbi.nlm.nih.gov/PMC10818242
https://doaj.org/article/20c42b5747184ad5897f8619b6577a7b
Volume 341
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB5tFyFxQbwJj8hIXNM2tR07x2XFqoC24sBKe4v8SKCr3XRVpSu4IH4TP4lfwowTLwQOSNwqx67szOfOfPXnGYCXHEOKHB8hN2lkJkSjM4zjbJZr7Sj3reWh2MTxqlieiLen8nQPingXJoj2nV1P2_OLabv-FLSVlxduFnVis_fHhznlYUPfMpvABBEaOfrw-1vwUFIOYxnkR4r0O-kvVdfVertD30OJuheCrurxOSUOJb-FrpGPvFNI4j9yUn8HoX9qKX9zTkd34PYQVbKDfvZ3Ya9u78HNvs7kl_tA1elYr9xgm4bJH9--M9N6xukD8v-sI491jmGnZ1SpAZHINi3raNTnQSnb0kjDQk8EXc3oYgo2rKgCCZ0Vs-Gsh4XFs6twHPAATo5efzhcZkPNhcwJLbtMF5ySOc4dem5fYBPxS1PM69LXJrfaecULvai9WnhnOLeNQwKVIysywjel5A9hH-ddPwaGXMe7gtLveyXKhTG4_ZU3zuK7amRjEpjFd11d9qk1qqg5O6uioSoyVNUbKoFXZJLr3pQaOzRsth-rASBVmLuVRLa1MF7qUjUaaaItpFJG2QTKaNBqiDL66AG_av3PCbyICKhwG9LZimnrzQ47lTkyMyG1SuBRj4jraUZwJaBHWBmtY_wEkR9SfUekP_n_oU_hFq2g1809g_1uu6ufYyDV2RQm0695CjcO3rxbrtLwd0Qa9tJPxQQiMg
link.rule.ids 230,315,730,783,787,867,888,2109,4511,24130,27938,27939,45599,45693,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RUFUuqO-m9OFKvaZL1nbsHCkqWgrspSBxs-w4oUFVglZZRG_9Tf1J_BJmnGS1aQ899Bb5EU08k5lvNOMZgI8cIUWCU-iblDIWotQx4jgXJ1rnVPvW8dBs4nSezs7F1wt5sQEHw10YSqvsdX-n04O27kcm_WlOrqtq8g3BClWXC1mQFFx6AFuIBjIU9q39o-PZfKWQUx56zNH6mDasXRS--nRTLZZojKhy91TQ3T1OuYlrNiqU8h-Zqr-h6J8ZlWsm6vAx7PTYku135D-BjaJ-Cg-7bpM_nwH1qGNd_gZrSibvfv1mtvaM00Pd1HFLdusHgk_PqF8DyiNratbSrts-X7amnZaFlSh6BaPrKTgwpz4kFDFmfcSHhS9mNyEo8BzOD7-cHczivvNCnAst21innEo67uVov32KQ-Rl2nSvyHxhE6dzr3iqp4VXU59bzl2ZoxuVoG9khS8zyV_AJtJdvAKGHo_PUyrC75XIptaiElDe5g7PqpSljWAynLW57gpsmCHz7MoM3DHEHdNxJ4LPxJLVaiqQHQaaxaXpJcQE2p0kl1sL66XOVKnRWXSpVMoqF0E2MNSM5A1fVf2TgA-DBBj8GSnCYuuiWeKiLEH_TEitInjZScSKTIJGiL54BHokK6PvGM_U1fdQ8DuhuoOIpV7_B9Hv4dHs7PTEnBzNj3dhm2a6VLo3sNkulsVbxFate9f_O_cZsyQ4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgCNQNb0p4FCOxzcxkHMfOEgqj8uioCypVYmH5kZSB1hkNmQpY8U18El_CvU5cSFkgdTdy7JEdn-SeK5-cS8gzBpQig0uQm9Q8zfNapsDjTJpJadH71rBQbGJvXuwe5G8O-WGvqvzSyyq9NYuRPz4Z-cXHoK1cnthx1ImN9_d2MvRhg9gyXrp6fJlcgYd2ImOm3r-FCxYKywGjgSxJoIpn-4-263SxWkMEQrvuaY4f7LEJ2odi9IIAyQYxKlj5D0LVv1T0vKLyrxA1u0E-xMV1ypTPo3VrRvb7Od_Hi63-JrneM1f6vOtzi1yq_G1ytatl-e0OwQp4tFOH0Kam_NePn1R7Rxn-8I1PW4yKx0BtHcVqEIB22nja4qivvRrX40hNQ08AdkXx4xdomGOVEzyPpv15Eg23lp6GI4e75GD26v3ObtrXdUhtLnmbyoKhYeTEAjtwBTRhDquLSVW6SmdGWidYIaeVE1NnNWOmtpCkZZB56dzVJWf3yAbMu7pPKORTzhZo8e9EXk61hleMcNoa2Ima1zoh47iTatnZd6ioa_ukIgwUwkB1MEjIC9zws95ovx0amtWR6rdBhbkbjgm9zLXjshS1hFTUFFwILUxCyggX1TOZjqHAXy3-O4GnEV8KHnU8v9G-atbQqcwg-8u5FAnZ6vB2Ns0I3YTIARIH6xheAXwFO_GIpwcXH_qEXNt_OVPvXs_fPiSbuJhOpveIbLSrdfUYeFtrtsMD-hvLnENU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+5%E2%80%B2+and+3%E2%80%B2+non-translated+regions+on+the+expression+of+a+transgene+from+a+Newcastle+disease+virus+vector&rft.jtitle=Virus+research&rft.au=Chowdhury%2C+Ishita+Roy&rft.au=Viktorova%2C+Ekaterina&rft.au=Samal%2C+Siba+K.&rft.au=Belov%2C+George+A.&rft.date=2024-03-01&rft.pub=Elsevier+B.V&rft.issn=0168-1702&rft.eissn=1872-7492&rft.volume=341&rft_id=info:doi/10.1016%2Fj.virusres.2024.199309&rft.externalDocID=S0168170224000029
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-1702&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-1702&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-1702&client=summon